الفرق بين المراجعتين لصفحة: «قالب:مضادات التخثر»

من موسوعة العلوم العربية
اذهب إلى التنقل اذهب إلى البحث
لا ملخص تعديل
ط (مراجعة واحدة)
(مراجعة متوسطة واحدة بواسطة نفس المستخدم غير معروضة)
سطر 1: سطر 1:
{{Navbox
{{Navbox
| name  = Antithrombotics
| name  = Antithrombotics
| title = Antithrombotics ([[thrombolytic drug|thrombolytics]], [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]]) [http://en.wikipedia.org/wiki/Template:Antithrombotics القالب الإنكليزي]
| title = [[Antithrombotic]]s ([[thrombolytic drug|thrombolytics]], [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]])
| groupstyle = background:MistyRose;  
| state = {{{state|autocollapse}}}
| bodyclass = hlist
| groupstyle = background:MistyRose; width:10em;
| liststyle = width:auto;


| group1 = [[Vitamin K]] antagonists
| group1 = [[Antiplatelet drug]]s
|  list1 = [[Acenocoumarol]] • [[Clorindione]] • [[Coumatetralyl]] • [[Dicoumarol]] (Dicumarol) • [[Diphenadione]] • [[Ethyl biscoumacetate]] • [[Phenprocoumon]] • [[Phenindione]] • [[Tioclomarol]] • [[Warfarin]]
|  list1 = {{Navbox subgroup
  | groupstyle = background-color: MistyRose; width:16em;
| liststyle = width:auto;


| group2 = مجموعة الهپارين
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
|  list2 = [[Antithrombin|Antithrombin III]] • [[Danaparoid]] • [[هپارين]] • [[Sulodexide]] • ''[[low molecular weight heparin]]'' ([[Bemiparin]], [[Dalteparin]], [[Enoxaparin]], [[Nadroparin]], [[Parnaparin]], [[Reviparin]], [[Tinzaparin]])
|  list1 =
* [[Abciximab]]
* [[Eptifibatide]]
* [[Tirofiban]]


| group3 = [[Glycoprotein IIb/IIIa inhibitors]]
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
|  list3 = [[Abciximab]] • [[Eptifibatide]] • [[Tirofiban]]
|  list2 =
* ''[[thienopyridine]]s''
** [[Clopidogrel]]
** [[Prasugrel]]
** [[Ticlopidine]]
* ''[[nucleotide]]/[[nucleoside]] analogs''
** [[Cangrelor]]
** [[Elinogrel]]
** [[Ticagrelor]]


| group4 = Other platelet<br>aggregation inhibitors
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]  • [[Aloxiprin]] • [[Ditazole]] • [[Carbasalate calcium]] • [[Cloricromen]] • [[Dipyridamole]] •  [[Indobufen]] • [[Picotamide]] • [[Triflusal]] • ''ADP receptor inhibitors'' ([[Clopidogrel]], [[Ticlopidine]], [[Prasugrel]]) • ''[[prostaglandin analogue]]'' ([[Beraprost]], [[Prostacyclin]], [[Iloprost]], [[Treprostinil]])
|  list3 =
* [[Beraprost]]
* [[Iloprost]]
* [[Prostacyclin]]
* [[Treprostinil]]


| group5 = إنزيمات
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
|  list5 = ''plasminogen activators'' ([[Tissue plasminogen activator|Alteplase]]/[[Reteplase]]/[[Tenecteplase]], [[Streptokinase]], [[Urokinase]]/[[Saruplase]], [[Anistreplase]], [[Monteplase]]) • ''other [[serine endopeptidase]]s'' ([[Ancrod]], [[Drotrecogin alfa]]/[[Protein C]], [[Fibrinolysin]]) • [[Brinase]]
|  list4 =
* [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>
* [[Aloxiprin]]
* [[Carbasalate calcium]]
* [[Indobufen]]
* [[Triflusal]]


| group6 = [[Direct thrombin inhibitor]]s
| group5 = [[Thromboxane inhibitors]]
|  list6 = [[Argatroban]] • [[Bivalirudin]] • [[Dabigatran]] • [[Desirudin]] • [[Hirudin]] • [[Lepirudin]] • [[Melagatran]] • [[Ximelagatran]]
|  list5 =
* ''[[thromboxane synthase inhibitors]]''
** [[Dipyridamole]]
** [[Picotamide]]
* ''[[Thromboxane receptor antagonist|receptor antagonist]]''
** [[Terutroban]]<sup>†</sup>


| group7 = Other antithrombotics
| group6 = [[Phosphodiesterase inhibitor]]s
|  list7 = [[Apixaban]] • [[Defibrotide]] • [[Dermatan sulfate]] • [[Fondaparinux]] • [[Idraparinux]] • [[Otamixaban]] • [[Ozagrel]] • [[Ramatroban]] • [[Rivaroxaban]]
|  list6 =
* [[Cilostazol]]
* [[Dipyridamole]]
* [[Triflusal]]


| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
| group7 = Other
|  list8 = [[Citrate]] • [[EDTA]] • [[Oxalate]]
|  list7 =
* [[Cloricromen]]
* [[Ditazole]]
}}
 
| group2 = [[Anticoagulant]]s
|  list2 = {{Navbox subgroup
  | groupstyle = background-color: MistyRose; width:16em;
  | liststyle = width:auto;
 
  | group2 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
  |  list2 =
* ''[[coumarin]]s:'' [[Acenocoumarol]]
* [[Coumatetralyl]]
* [[Dicoumarol]]
* [[Ethyl biscoumacetate]]
* [[Phenprocoumon]]
* [[Warfarin]]<sup>#</sup>
*''[[1,3-Indandione]]s:'' [[Clorindione]]
* [[Diphenadione]]
* [[Phenindione]]
* ''other:'' [[Tioclomarol]]
 
| group3 = [[Factor Xa]] inhibitors<br />(with some II inhibition)
|  list3 = {{Navbox subgroup
  | groupstyle = background-color: MistyRose
 
| group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
| list1  =
* ''[[low molecular weight heparin]]''
** [[Bemiparin sodium|Bemiparin]]
** [[Certoparin sodium|Certoparin]]
** [[Dalteparin sodium|Dalteparin]]
** [[Enoxaparin sodium|Enoxaparin]]
** [[Nadroparin calcium|Nadroparin]]
** [[Parnaparin sodium|Parnaparin]]
** [[Reviparin sodium|Reviparin]]
** [[Tinzaparin sodium|Tinzaparin]]
* ''[[oligosaccharide]]s''
** [[Fondaparinux]]
** [[Idraparinux]]
* ''[[heparinoid]]''
** [[Danaparoid]]
** [[Dermatan sulfate]]
** [[Sulodexide]]
 
| group2 = [[Direct Xa inhibitor]]s
|  list2 =
* ''xabans''
** [[Apixaban]]
** [[Betrixaban]]
** [[Edoxaban]]
** [[Otamixaban]]
** [[Rivaroxaban]]
}}
 
| group5 = [[Direct thrombin inhibitor|Direct thrombin (II) inhibitor]]s
|  list5 =
* ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]]
** [[Bivalirudin]]
** [[Desirudin]]
** [[Lepirudin]]
* ''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]
* [[Dabigatran]]
* [[Melagatran]]<sup>‡</sup>
* [[Ximelagatran]]<sup>‡</sup>
 
| group6 = Other
|  list6 =
* [[Antithrombin|Antithrombin III]]
* [[Defibrotide]]
* [[Protein C]]
** [[Drotrecogin alfa]]
* [[Ramatroban]]
* [[REG1<!--instantly reversible aptamer-based direct FIXa inhibitor in IIb trials -->]]
}}
 
| group3 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
|  list3 =
* ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]''
** [[Tissue plasminogen activator|Alteplase]]
** [[Reteplase]]
** [[Tenecteplase]]
* ''UPA''
** [[Saruplase]]
** [[Urokinase]]
* [[Anistreplase]]
* [[Monteplase]]
* [[Streptokinase]]<sup>#</sup>
*''other [[serine endopeptidase]]s:'' [[Ancrod]]
* [[Brinase]]
* [[Fibrinolysin]]
 
| group4 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
|  list4 =
* [[Citrate]]
* [[Ethylenediaminetetraacetic acid|EDTA]]
* [[Oxalate]]
 
| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}} {{Myeloid navs}}


}}<noinclude>
}}<noinclude>
{{collapsible option}}
[[Category:Antithrombotic agents]]
[[Category:Drug_templates by ATC]]


[[تصنيف:جداول تصفح الأدوية|{{PAGENAME}}]]
</noinclude>
</noinclude>

مراجعة 15:34، 7 أغسطس 2013

Note to editors on how to manage collapsibility:

  • Use {{مضادات التخثر|state=collapsed}} to show this template in its collapsed (hidden) state.
  • Use {{مضادات التخثر|state=expanded}} to show this template in its expanded (fully visible) state.
  • Use {{مضادات التخثر|state=autocollapse}} to show this template in its collapsed (hidden) state only if there is another template of the same type on the page. (This is usually the default.)


مجلوبة من «http://www.arabsciencepedia.org/w/index.php?title=قالب:مضادات_التخثر&oldid=27315»